[Neurological complications of treatments with vincristine. Clinical study of 100 patients treated with vincristine].
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002493:Central Nervous System Diseases / Q000139:chemically induced; D004338:Drug Combinations; D005334:Fever / Q000139:chemically induced; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007418:Intestinal Pseudo-Obstruction / Q000139:chemically induced; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D001523:Mental Disorders / Q000139:chemically induced; D009422:Nervous System Diseases / Q000139:chemically induced*; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced; D012640:Seizures / Q000139:chemically induced; D014750:Vincristine / Q000009:adverse effects* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D004338:Drug Combinations; D014750:Vincristine
Les complications neurologiques des traitements par la Vincristine. Etude clinique à partir de 100 malades soumis à un traitement par la Vincristine